CAPTRUST Financial Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $300K | Hold |
2,534
| – | – | ﹤0.01% | 2598 |
|
|
2026
Q1 | $263K | Hold |
2,534
| – | – | ﹤0.01% | 2475 |
|
|
2025
Q4 | $265K | Hold |
2,534
| – | – | ﹤0.01% | 2338 |
|
|
2025
Q3 | $234K | Hold |
2,534
| – | – | ﹤0.01% | 2327 |
|
|
2025
Q2 | $202K | Hold |
2,534
| – | – | ﹤0.01% | 2300 |
|
|
2025
Q1 | $219K | Sell |
2,534
-231
| -8% | -$19.7K | ﹤0.01% | 2118 |
|
|
2024
Q4 | $228K | Hold |
2,765
| – | – | ﹤0.01% | 2076 |
|
|
2024
Q3 | $240K | Hold |
2,765
| – | – | ﹤0.01% | 2020 |
|
|
2024
Q2 | $227K | Hold |
2,765
| – | – | ﹤0.01% | 1970 |
|
|
2024
Q1 | $222K | Hold |
2,765
| – | – | ﹤0.01% | 1944 |
|
|
2023
Q4 | $210K | Hold |
2,765
| – | – | ﹤0.01% | 2364 |
|
|
2023
Q3 | $200K | Hold |
2,765
| – | – | ﹤0.01% | 2295 |
|
|
2023
Q2 | $209K | Hold |
2,765
| – | – | ﹤0.01% | 2235 |
|
|
2023
Q1 | $210K | Hold |
2,765
| – | – | ﹤0.01% | 2022 |
|
|
2022
Q4 | $217K | Buy |
+2,765
| New | +$213K | ﹤0.01% | 1893 |
|
|
2022
Q3 | – | Sell |
-1,765
| Closed | -$132K | – | 3485 |
|
|
2022
Q2 | $132K | Hold |
1,765
| – | – | ﹤0.01% | 2005 |
|
|
2022
Q1 | $140K | Hold |
1,765
| – | – | ﹤0.01% | 1997 |
|
|
2021
Q4 | $143K | Hold |
1,765
| – | – | ﹤0.01% | 1890 |
|
|
2021
Q3 | $137K | Hold |
1,765
| – | – | ﹤0.01% | 1829 |
|
|
2021
Q2 | $142K | Hold |
1,765
| – | – | ﹤0.01% | 1766 |
|
|
2021
Q1 | $139K | Hold |
1,765
| – | – | ﹤0.01% | 1735 |
|
|
2020
Q4 | $126K | Hold |
1,765
| – | – | ﹤0.01% | 1400 |
|
|
2020
Q3 | $113K | Hold |
1,765
| – | – | ﹤0.01% | 1294 |
|
|
2020
Q2 | $115K | Hold |
1,765
| – | – | ﹤0.01% | 1287 |
|
|
2020
Q1 | $94K | Buy |
+1,765
| New | +$107K | ﹤0.01% | 1147 |
|
|
2019
Q4 | – | Sell |
-1,765
| Closed | -$100K | – | 1576 |
|
|
2019
Q3 | $100K | Hold |
1,765
| – | – | ﹤0.01% | 776 |
|
|
2019
Q2 | $106K | Hold |
1,765
| – | – | ﹤0.01% | 741 |
|
|
2019
Q1 | $115K | Hold |
1,765
| – | – | ﹤0.01% | 650 |
|
|
2018
Q4 | $110K | Sell |
1,765
-50
| -3% | -$3.38K | 0.01% | 560 |
|
|
2018
Q3 | $133K | Hold |
1,815
| – | – | 0.01% | 519 |
|
|
2018
Q2 | $122K | Hold |
1,815
| – | – | 0.01% | 459 |
|
|
2018
Q1 | $110K | Hold |
1,815
| – | – | 0.01% | 428 |
|
|
2017
Q4 | $116K | Hold |
1,815
| – | – | 0.01% | 418 |
|
|
2017
Q3 | $117K | Buy |
+1,815
| New | +$115K | 0.01% | 239 |
|
|
2017
Q1 | – | Sell |
-250
| Closed | -$14K | – | 155 |
|
|
2016
Q4 | $14K | Buy |
+250
| New | +$14.4K | ﹤0.01% | 145 |
|
|
2016
Q2 | – | Sell |
-250
| Closed | -$15K | – | 158 |
|
|
2016
Q1 | $15K | Buy |
+250
| New | +$15.3K | ﹤0.01% | 162 |
|
Other funds holding PJP
PAM
JGCM
CAPTRUST Financial Advisors's PJP Position: Q2 2026 in Review
CAPTRUST Financial Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 2,534 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2598.
CAPTRUST Financial Advisors first reported a position in PJP in Q1 2016 and has held it in 36 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- CAPTRUST Financial Advisors held 2,534 shares of Invesco Pharmaceuticals ETF worth $300K as of Q2 2026.
- CAPTRUST Financial Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2598 holding.
- CAPTRUST Financial Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and has held it in 36 quarters since.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.